Loading company…
Riskpilot
← Back to search
Sign in
Get full access
COMO BIOTECH ApS
APS
Dissolved
CVR 25349512
Åbogade 15
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2000
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2016
DKK -32K
+8% vs 2015
EBITDA margin
100.0%
-8% vs 2015
Equity ratio
73.3%
Financial strength
Net profit 2016
DKK -38K
-60% vs 2015
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
0%
2013
0M
0%
2014
0M
0%
2015
0M
0%
2016
Key figures
Annual report 2016
Revenue
DKK -32K
+8%
EBITDA
DKK -32K
-8%
Net profit
DKK -38K
-60%
Total assets
DKK 234K
-13%
Equity
DKK 172K
-18%
Employees
—
—
Company information
Legal name
COMO BIOTECH ApS
CVR number
25349512
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
28. april 2000
Share capital
DKK 167.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2016-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af en direktør eller af den samlede bestyrelse
Contact
Address
Åbogade 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Aarhus
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
0M
2016
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
0M
2016
Income statement
DKK thousands
Item
2012
2013
2014
2015
2016
Revenue
72
-65
248
-29
-32
Staff expenses
-0
-0
-0
-0
-0
EBITDA
26
-65
248
-29
-32
Depreciation & amort.
-72
-0
-0
-0
-0
EBIT
-46
-65
248
-29
-32
Net financials
3
0
4
0
-0
Profit before tax
-23
-65
253
-29
-32
Tax
10
-12
60
-6
6
Net profit
-33
-52
192
-24
-38
Balance sheet
DKK thousands
Item
2012
2013
2014
2015
2016
Total assets
287
154
385
269
234
Equity
172
120
313
209
172
Long-term debt
0
0
0
0
0
Short-term debt
115
34
72
60
63
Total debt
115
34
72
60
63
Financial ratios
5-year trend
EBITDA margin
-3175200.0%
This company
15.8%
Market median
-20096303% vs market
2012
2016
Equity ratio
73.3%
This company
38.2%
Market median
+92% vs market
2012
2016
Return on equity
-21.9%
This company
18.4%
Market median
-219% vs market
2012
2016
Net profit margin
-3762400.0%
This company
8.1%
Market median
-46449483% vs market
2012
2016
Asset turnover
-0.14×
This company
1.12×
Market median
-113% vs market
2012
2016
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
2012
2016
Annual reports & filings
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
CO
Claus Oxvig
Management
Management
2000
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
LH
Lars Henning Stigel
Board of Directors
2000
—
—
MT
Michael Toft Overgaard
Chairman
2012
—
—
JF
Jørn Frederik Falch
Board of Directors
2012
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
COMO HOLDING ApS
Company
100.0%
100.0%
2014
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of COMO BIOTECH ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Claus Oxvig
Management
0 companies
Lars Henning Stigel
Board of Directors
0 companies
Michael Toft Overgaard
Chairman
0 companies
Jørn Frederik Falch
Board of Directors
0 companies